Vikhanskaya, F <br/><br/>
Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.  [electronic resource] 

 -  Experimental cell research  Sep 1996 
 - 380-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4827 
<br/><br/><label>Standard No.: </label>10.1006/excr.1996.0288  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amsacrine--pharmacology<br/>Antibiotics, Antineoplastic--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Blotting, Northern<br/>CDC2 Protein Kinase--genetics<br/>Cyclin B<br/>Cyclin B1<br/>Cyclin D1<br/>Cyclin-Dependent Kinases--genetics<br/>Cyclins--genetics<br/>DNA Damage<br/>DNA, Neoplasm--drug effects<br/>Doxorubicin--pharmacology<br/>Female<br/>Gene Expression Regulation, Neoplastic--physiology<br/>Humans<br/>Mutation--physiology<br/>Oncogene Proteins--genetics<br/>Ovarian Neoplasms<br/>Tumor Cells, Cultured--drug effects<br/>Tumor Suppressor Protein p53--genetics